← All trials
NCT04754061
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2022
- Primary completion
- Feb 28, 2023
- Completion date
- Aug 31, 2024
- First posted
- Feb 15, 2021
- Last posted
- Nov 18, 2021
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of OttawaLead sponsor
- University of OttawaOverall official - principal investigator
- University of OttawaCollaborator
- University of Western OntarioCollaborator
- Laval UniversityCollaborator
- McGill UniversityCollaborator
- University of SherbrookeCollaborator
- University of OttawaReponsible party - principal investigator
- Bruyere Research InstituteCollaborator
- William Osler Health Service BramptonCollaborator
- Kingston Health Sciences CentreCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.